BridgeMD
New treatment option for Diastasis Recti
Official title Effects of Drawing in Maneuver and Resisted Ankle Dorsiflexion in Postpartum Diastasis Recti
ClinicalTrials.gov ID: NCT07520409
What this study is testing
- What it's testing
- The aim of this study is to compare the combine effects of drawing in maneuver and resisted ankle dorsiflexion on pain, inter-recti distance, strength and quality of life in postpartum diastasis recti.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 20 to 45, women only. Healthy volunteers may be eligible.
You may be able to join if
- Postpartum females (6 weeks to 6 months postpartum)
- Diagnosed with diastasis recti (IRD ≥ 2.5 cm)
- Age 20-45 years
- Mode of delivery
- Multiparity
You likely can't join if
- History of abdominal surgery
- Pelvic organ prolapses
- Neurological or orthopedic disorders
- Presence of low back pain, hernia, or musculoskeletal disorders
- Participation in any other abdominal rehabilitation program in the last 3 months
The study team makes the final eligibility decision.
Where it's taking place
- Guiranwala, Punjab Province, Pakistan
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 20 years to 45 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Guiranwala, Punjab Province, Pakistan. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.